Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?A Graham Macdonald, Mira Keyes, Alexandra Kruk, et al.
JMIR Mhealth and Uhealth|November 12, 2021
Experiences of Wearable Technology by Persons with Knee Osteoarthritis Participating in a Physical Activity Counseling Intervention: Qualitative Study Using a Relational Ethics LensJenny Leese, Graham MacDonald, Catherine L Backman, et al.
British Journal of Cancer|April 16, 2002
A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary siteA Graham Macdonald, M C Nicolson, L M Samuel, et al.
European Journal of Cancer Care|January 17, 2020
Definitive chemoradiotherapy for cervical cancer: A 11-year population-based studyEmmanouil Kalampokas, Graham Macdonald, Helena Young, et al.
Clinical Genitourinary Cancer|December 20, 2018
High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland ExperienceYun Yi Tan, Bahaa Al-Bubseeree, David Irvine, et al.
BMJ Open|August 20, 2018
'Adding another spinning plate to an already busy life'. Benefits and risks in patient partner-researcher relationships: a qualitative study of patient partners' experiences in a Canadian health research settingJenny Leese, Graham Macdonald, Sheila Kerr, et al.
The Journal of the Royal College of Physicians of Edinburgh|April 20, 2021
Challenging presentations of germ cell tumours in routine clinical practiceNavya Bezawada, Arthur Norton, Karen Mactier, et al.
BMJ Open Quality|March 28, 2020
Testicular cancer: improving outcomes with national quality performance indicatorsMark A Baxter, Graham MacDonald, Jahangeer Malik, et al.
BMC Cancer|December 17, 2009
APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profilingRussell D Petty, Leslie M Samuel, Graeme I Murray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder CancerThomas Powles, Robert A Huddart, Tony Elliott, et al.
Pageof 3